COSTA, Loredana
 Distribuzione geografica
Continente #
NA - Nord America 821
EU - Europa 244
AS - Asia 178
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.246
Nazione #
US - Stati Uniti d'America 821
CN - Cina 91
UA - Ucraina 76
DE - Germania 51
SG - Singapore 45
IT - Italia 36
FI - Finlandia 23
HK - Hong Kong 21
TR - Turchia 14
IE - Irlanda 12
FR - Francia 11
RU - Federazione Russa 10
GB - Regno Unito 8
GR - Grecia 6
CZ - Repubblica Ceca 3
EU - Europa 3
IN - India 3
AL - Albania 2
ES - Italia 2
ID - Indonesia 2
AT - Austria 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
SE - Svezia 1
SI - Slovenia 1
Totale 1.246
Città #
Fairfield 105
Ashburn 90
Chandler 77
Woodbridge 73
Houston 72
Jacksonville 51
Singapore 43
Cambridge 37
Seattle 37
Wilmington 37
Dearborn 25
New York 25
Princeton 24
Ann Arbor 20
Hong Kong 20
Beijing 19
Helsinki 17
Dublin 12
Istanbul 12
Shanghai 10
Brescia 9
Nanchang 9
Nanjing 9
Changsha 8
Munich 7
Athens 6
Ceto 6
Des Moines 6
San Diego 6
Washington 6
Boardman 4
Falls Church 4
Kunming 4
Moscow 4
Shenyang 4
Guangzhou 3
Haikou 3
Hangzhou 3
Hebei 3
Jinan 3
London 3
Los Angeles 3
Milan 3
Tianjin 3
Brno 2
Gunzenhausen 2
Jakarta 2
Kocaeli 2
Lancaster 2
Ningbo 2
Redwood City 2
San Francisco 2
Santa Clara 2
Tirana 2
Berlin 1
Böblingen 1
Cambados 1
Chengdu 1
Chicago 1
Hefei 1
Hounslow 1
Jiaxing 1
Kuwait City 1
Ljubljana 1
Luoyang 1
Newark 1
Olomouc 1
Orange 1
Rende 1
Reykjavik 1
Romola 1
Taizhou 1
Treviglio 1
Verona 1
Vienna 1
Vientiane 1
Zhengzhou 1
Totale 968
Nome #
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 145
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 141
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 136
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 133
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 131
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 114
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 112
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 91
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 81
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 74
The linguistic validation process of the Vanderbilt Head and Neck Symptom Survey - Italian Version (VHNSS-IT) 73
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 44
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 19
Totale 1.294
Categoria #
all - tutte 6.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020192 0 0 0 0 0 42 35 29 19 42 10 15
2020/2021213 6 18 14 20 5 25 2 25 19 40 19 20
2021/2022107 6 4 5 7 4 7 2 10 5 16 6 35
2022/2023170 13 12 4 17 21 32 0 18 37 1 8 7
2023/2024166 8 3 25 11 6 41 14 7 20 4 7 20
2024/202598 4 1 2 50 15 26 0 0 0 0 0 0
Totale 1.294